According to Actinium Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.82. In 2022 the company made an earnings per share (EPS) of -$1.37 a decrease over its 2021 EPS that were of -$1.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.82 | 32.85% |
2022 | -$1.37 | 14.17% |
2021 | -$1.20 | -43.4% |
2020 | -$2.12 | -52.98% |
2019 | -$4.51 | -31.68% |
2018 | -$6.60 | -46.34% |
2017 | -$12.30 | -18% |
2016 | -$15.00 | -9.09% |
2015 | -$16.50 | -38.89% |
2014 | -$27.00 | 91.49% |
2013 | -$14.10 | -88.41% |
2012 | -$121.64 | 1251.63% |
2011 | -$9.00 | 3.2423204348652E+19% |
2010 | -$0.0000000000 | |
2009 | N/A | -100% |
2008 | -$0.30 | -39.06% |
2007 | -$0.49 |